Does switching from Ajovy to Emgality reset your body’s treatment?
Generally, no. Both Ajovy (fremanezumab) and Emgality (galcanezumab) are CGRP monoclonal antibodies used for migraine prevention. They block the CGRP pathway, so the goal of treatment stays the same rather than restarting a whole new therapy from zero.
That said, each medication is different (different antibody targets within the same CGRP pathway), so your response time after switching can vary by person.
How long does it take for Emgality to start working after stopping Ajovy?
There isn’t a single guaranteed timeline, but in practice clinicians usually expect a continued migraine-prevention effect fairly soon after starting the new CGRP antibody. Some people notice improvement within the first couple of doses, while others take longer to see the full benefit.
What matters most is when you stop Ajovy and when you start the next Emgality dose, since there can be a gap if the schedules don’t line up.
Is there an overlap period, or do you switch directly?
Often the switch is made to match the dosing schedule, not to “wash out” your system. Because both are long-acting injections, doctors typically plan the timing around:
- the last Ajovy dose date, and
- the Emgality loading dose vs maintenance schedule.
Your prescriber may recommend a direct switch with timing adjustments to avoid long gaps, but the exact plan depends on your dosing history (monthly vs quarterly Ajovy, and your Emgality regimen).
Will you lose progress you had on Ajovy?
Most people do not “lose” progress permanently, but some do notice a change in control when switching. That can happen for reasons like:
- individual differences in response to each antibody, or
- delays/coverage gaps during the transition.
If Ajovy was working well and Emgality doesn’t, your clinician can consider going back to Ajovy, trying another CGRP option, or switching to a different class of preventive therapy.
Do side effects reset too?
Side effects from CGRP monoclonal antibodies are usually tied to exposure and individual sensitivity, not to “starting from scratch.” If you had side effects on Ajovy, you might or might not have the same ones on Emgality. If you had no side effects, you still could develop them after switching, but many patients tolerate the new drug similarly.
What’s the safest way to time the switch?
The safest approach is to follow your prescriber’s dose calendar based on your:
- last Ajovy injection date, and
- whether you took Ajovy monthly or quarterly,
then start Emgality on the planned date (often using the standard loading/maintenance approach).
If you tell me whether you took Ajovy monthly or quarterly and the date of your last Ajovy shot, I can help you think through what questions to ask your prescriber about timing (not personal medical advice).